OREON Life Science Participates in AMWC 2025 Monaco
OREON Life Science participated in the AMWC 2025 (Aesthetic & Anti-Aging Medicine World Congress) held in Monaco from March 27th to 29th. The company proved its technological competitiveness on the global stage by showcasing an integrated aesthetic solution portfolio covering skin hydration, elasticity improvement, and volume enhancement.
At this exhibition, OREON presented six core products, including the i-Series—consisting of the ▲monophasic HA filler i-LEAD, ▲PN-containing skin booster i-JUV, and ▲hybrid filler i-NOVA for hydration and regeneration—along with ▲PLLA-based biostimulators PiNkLLA and aesplla, ▲exosome skin booster EXOJUV, and ▲lipolysis solution Pink Bottle.
In particular, the flagship i-Series was highly praised by global distributors and aesthetic experts for its potential as a customized portfolio that can be flexibly applied according to skin conditions and treatment areas. i-NOVA, which precisely blends high and low-molecular weight hyaluronic acid, achieves deep skin hydration and elasticity improvement simultaneously. It differentiates itself from existing skin boosters by adding active ingredients that induce regeneration, such as amino acids, succinic acid, and glutathione.
Additionally, the PLLA-based skin booster PiNkLLA drew significant interest from on-site buyers sensitive to biostimulation trends, as it induces the skin's natural collagen production for natural elasticity improvement and volume restoration.
An official from OREON Life Science stated, "In this exhibition, we focused on introducing products based on our design capability through a multi-layered understanding of the skin, rather than just listing functions. Global buyers and industry experts resonated with the fact that while each product can be used independently, they can also be combined organically according to the purpose and stage of treatment."
Participation in AMWC 2025 served as an opportunity to reaffirm the brand's competitiveness and technical reliability in the global market. Based on this, OREON plans to full-scale its global partnership expansion and market entry, particularly in Europe and the Middle East. The company intends to continue expanding its problem-solving-oriented product portfolio to address various skin concerns and present competitive K-medical aesthetic solutions on the international stage.
👉 https://www.medifonews.com/news/article.html?no=201349
👉 https://www.rapportian.com/news/articleView.html?idxno=219488
OREON Life Science Participates in AMWC 2025 Monaco
OREON Life Science participated in the AMWC 2025 (Aesthetic & Anti-Aging Medicine World Congress) held in Monaco from March 27th to 29th. The company proved its technological competitiveness on the global stage by showcasing an integrated aesthetic solution portfolio covering skin hydration, elasticity improvement, and volume enhancement.
At this exhibition, OREON presented six core products, including the i-Series—consisting of the ▲monophasic HA filler i-LEAD, ▲PN-containing skin booster i-JUV, and ▲hybrid filler i-NOVA for hydration and regeneration—along with ▲PLLA-based biostimulators PiNkLLA and aesplla, ▲exosome skin booster EXOJUV, and ▲lipolysis solution Pink Bottle.
In particular, the flagship i-Series was highly praised by global distributors and aesthetic experts for its potential as a customized portfolio that can be flexibly applied according to skin conditions and treatment areas. i-NOVA, which precisely blends high and low-molecular weight hyaluronic acid, achieves deep skin hydration and elasticity improvement simultaneously. It differentiates itself from existing skin boosters by adding active ingredients that induce regeneration, such as amino acids, succinic acid, and glutathione.
Additionally, the PLLA-based skin booster PiNkLLA drew significant interest from on-site buyers sensitive to biostimulation trends, as it induces the skin's natural collagen production for natural elasticity improvement and volume restoration.
An official from OREON Life Science stated, "In this exhibition, we focused on introducing products based on our design capability through a multi-layered understanding of the skin, rather than just listing functions. Global buyers and industry experts resonated with the fact that while each product can be used independently, they can also be combined organically according to the purpose and stage of treatment."
Participation in AMWC 2025 served as an opportunity to reaffirm the brand's competitiveness and technical reliability in the global market. Based on this, OREON plans to full-scale its global partnership expansion and market entry, particularly in Europe and the Middle East. The company intends to continue expanding its problem-solving-oriented product portfolio to address various skin concerns and present competitive K-medical aesthetic solutions on the international stage.
👉 https://www.medifonews.com/news/article.html?no=201349
👉 https://www.rapportian.com/news/articleView.html?idxno=219488